Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stratigos

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2021
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomasJ J Grob, C Gaudy-Marqueste, A Guminski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2021
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognitionJ J Grob, A Guminski, J Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statementZ Apalla, V Nikolaou, D Fattore, et al.
Sexual Health|August 13, 2024
Key findings from the 2023 'ACT NOW on Global HIV Migration, Mobility and Health Equity' community forumN Wells, J J Ong, L Stackpool-Moore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT studyJ T Lear, M R Migden, K D Lewis, et al.
Nature Communications|December 19, 2025
The molecular cartography of malignant and benign sebaceous tumoursI Ferreira, O M Rueda, L van der Weyden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 13, 2020
Dermatoscopic features of thin (≤2 mm Breslow thickness) vs. thick (>2 mm Breslow thickness) nodular melanoma and predictors of nodular melanoma versus nodular non-melanoma tumours: a multicentric collaborative study by the International Dermoscopy SocietyD Sgouros, A Lallas, H Kittler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesL Kandolf-Sekulovic, K Peris, A Stratigos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2025
Epidemiology and management of pemphigus in Greece: A 5-year, multicentre studyM P Konstantinou, A Patsatsi, A Chatziperrou, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2021
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomasJ J Grob, C Gaudy-Marqueste, A Guminski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2021
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognitionJ J Grob, A Guminski, J Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statementZ Apalla, V Nikolaou, D Fattore, et al.
Sexual Health|August 13, 2024
Key findings from the 2023 'ACT NOW on Global HIV Migration, Mobility and Health Equity' community forumN Wells, J J Ong, L Stackpool-Moore, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT studyJ T Lear, M R Migden, K D Lewis, et al.
Nature Communications|December 19, 2025
The molecular cartography of malignant and benign sebaceous tumoursI Ferreira, O M Rueda, L van der Weyden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 13, 2020
Dermatoscopic features of thin (≤2 mm Breslow thickness) vs. thick (>2 mm Breslow thickness) nodular melanoma and predictors of nodular melanoma versus nodular non-melanoma tumours: a multicentric collaborative study by the International Dermoscopy SocietyD Sgouros, A Lallas, H Kittler, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesL Kandolf-Sekulovic, K Peris, A Stratigos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2025
Epidemiology and management of pemphigus in Greece: A 5-year, multicentre studyM P Konstantinou, A Patsatsi, A Chatziperrou, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.
Pageof 10